Company / Current Assets per Share
Fulgent Genetics, Inc. Current Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets per Share
$17.85
FY2025
5-year range
$11.92 / $21.72
FY2021-FY2025
Trend
+49.7%
vs FY2024
Sector context
#61 of 158
Health Care
What the data says
At $17.85, Fulgent Genetics, Inc.'s current assets per share ranks #61 of 158 in the Health Care sector. Current Assets per Share returned to growth in FY2025 after 4 years of decline, reaching $17.85.
Based on SEC 10-K filings.
17.85 in FY2025 with a 5-year CAGR of -6.0%.
Improved from $17.25 to $17.85 over the past 2 years.
Health Care sector context is included.
Current Assets per Share over time
Growth rates
- 3-Year CAGR
- -5.0%
- 5-Year CAGR
- -6.0%
- 10-Year CAGR
- -
Sector benchmark
#61 of 158 in Health CareTop 39% of 158This company $17.85 Sector average $54.20
▼
-67.1% below sector average
Key checks
Key Insights
- In FY2025, current assets per share increased 49.7% year-over-year.
- Ranks #61 out of 158 companies in the Health Care sector.
- Peak current assets per share was recorded in FY2020.
- Lowest current assets per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score 5.28 (safe zone, above 2.9 threshold)
- Negative profit margin: -15.1%
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.85 | +49.7% |
| FY2024 | $11.92 | -30.9% |
| FY2023 | $17.25 | -17.1% |
| FY2022 | $20.82 | -4.1% |
| FY2021 | $21.72 | -10.9% |
| FY2020 | $24.37 | +1094.5% |
| FY2019 | $2.04 | -7.9% |
| FY2018 | $2.22 | +18.9% |
| FY2017 | $1.86 | +26.0% |
| FY2016 | $1.48 | +497.6% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026